{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:32:46Z","timestamp":1792801966623,"version":"4.5.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"\"Zhiyuan\" Talent Program of Inner Mongolia Medical University","award":["NO.ZY20241101"],"award-info":[{"award-number":["NO.ZY20241101"]}],"id":[{"id":"https:\/\/ror.org\/01mtxmr84","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Special Project for Enhancing the Research Capacity of the Clinical Medicine Discipline of the Affiliated Hospital of Inner Mongolia Medical University","award":["NO.NYFY2025LCYXXK008"],"award-info":[{"award-number":["NO.NYFY2025LCYXXK008"]}],"id":[{"id":"https:\/\/ror.org\/01mtxmr84","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hereditas"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Colorectal cancer (CRC) is a common malignant tumor with a steadily rising incidence rate, and it is often diagnosed at an advanced stage. Immunotherapy has emerged as a promising alternative to surgical resection. Cancer-associated fibroblasts (CAFs) play a critical role in the tumor microenvironment (TME) and are closely associated with tumor immune evasion. This study aims to identify genes associated with CAFs and immune evasion in CRC, and to explore their underlying mechanisms and potential clinical applications in CRC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Based on CRC transcriptomic data from TCGA and GEO (GSE39582), this study identified differentially expressed genes associated with tumor-associated fibroblasts and immune evasion (CAFIERDEGs) and performed GO\/KEGG functional enrichment analysis on them. A prognostic risk model was constructed based on CAFIERDEGs, followed by survival analysis and validation. Additionally, key genes were identified through the construction of a protein-protein interaction (PPI) network, and differences in immune checkpoint expression, immune cell infiltration, and immunotherapy response were systematically evaluated across different risk groups. Finally, the key genes were experimentally validated using single-cell RNA sequencing, immunohistochemistry, and qPCR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Five hub genes (SOX2, CXCL11, SPP1, APOE, and CXCL8) were screened. These genes are involved in the regulation of the immune response, cytokine activity, and the Toll-like receptor signaling pathway. CRC patients were classified into two distinct molecular subtypes based on the expression profiles of these genes. The prognostic risk model revealed significant differences in overall survival rates. The tumor immune dysfunction and rejection (TIDE) score was significantly lower in the low-risk group. The tumor mutational burden (TMB) was higher, and the expression of most immune checkpoint genes increased. This indicates a stronger potential reactivity to immunotherapy. Experiments confirmed that the expressions of CXCL8, CXCL11, and SPP1 were significantly upregulated in CAFs, while APOE and SOX2 expressions were significantly downregulated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study identified five CAFIERGs and constructed a prognostic model for CRC by integrating CAFs and immune escape-related genes. This model can predict the immunotherapy response and prognosis of CRC patients. These findings offer potential therapeutic targets for improving prognostic evaluation and guiding immunotherapy strategies in CRC patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41065-026-00676-9","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T06:26:46Z","timestamp":1775543206000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cancer-associated fibroblasts and immune escape-related genes serve as biological markers for the prognosis of colorectal cancer"],"prefix":"10.1186","volume":"163","author":[{"given":"Xia","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aorong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bai","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fen","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rina","family":"Sha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongfeng","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,7]]},"reference":[{"issue":"1","key":"676_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348. https:\/\/doi.org\/10.3322\/caac.21763.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"676_CR2","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","volume":"20","author":"E Sahai","year":"2020","unstructured":"Sahai E, Astsaturov I, Cukierman E, DeNardo DG, Egeblad M, Evans RM, et al. A framework for advancing our understanding of cancer-associated fibroblasts. Nat Rev Cancer. 2020;20(3):174\u201386. https:\/\/doi.org\/10.1038\/s41568-019-0238-1.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"676_CR3","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41573-018-0004-1","volume":"18","author":"X Chen","year":"2029","unstructured":"Chen X, Song E. Turning foes to friends: targeting cancer-associated fibroblasts. Nat Rev Drug Discov. 2029;18(2):99\u2013115. https:\/\/doi.org\/10.1038\/s41573-018-0004-1.","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"676_CR4","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1038\/s41467-018-03347-0","volume":"9","author":"MA Lakins","year":"2018","unstructured":"Lakins MA, Ghorani E, Munir H, Martins CP, Shields JD. Cancer-associated fibroblasts induce antigen-specific deletion of CD8\u2009+\u2009T Cells to protect tumour cells. Nat Commun. 2018;9(1):948. https:\/\/doi.org\/10.1038\/s41467-018-03347-0.","journal-title":"Nat Commun"},{"key":"676_CR5","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.3389\/fimmu.2019.01835","volume":"10","author":"L Monteran","year":"2019","unstructured":"Monteran L, Erez N. The Dark Side of Fibroblasts: Cancer-Associated Fibroblasts as Mediators of Immunosuppression in the Tumor Microenvironment. Front Immunol. 2019;10:1835. https:\/\/doi.org\/10.3389\/fimmu.2019.01835.","journal-title":"Front Immunol"},{"issue":"5","key":"676_CR6","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.ccell.2017.10.005","volume":"32","author":"V Kumar","year":"2017","unstructured":"Kumar V, Donthireddy L, Marvel D, Condamine T, Wang F, Lavilla-Alonso S, et al. Cancer-Associated Fibroblasts Neutralize the Anti-tumor Effect of CSF1 Receptor Blockade by Inducing PMN-MDSC Infiltration of Tumors. Cancer Cell. 2017;32(5):654\u2013e6685. https:\/\/doi.org\/10.1016\/j.ccell.2017.10.005.","journal-title":"Cancer Cell"},{"issue":"17","key":"676_CR7","doi-asserted-by":"publisher","first-page":"3026","DOI":"10.2174\/0929867324666170830111531","volume":"26","author":"W Zhou","year":"2019","unstructured":"Zhou W, Guo S, Liu M, Burow ME, Wang G. Targeting CXCL12\/CXCR4 Axis in Tumor Immunotherapy. Curr Med Chem. 2019;26(17):3026\u201341. https:\/\/doi.org\/10.2174\/0929867324666170830111531.","journal-title":"Curr Med Chem"},{"issue":"1","key":"676_CR8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12943-025-02243-8","volume":"24","author":"Y Xie","year":"2025","unstructured":"Xie Y, Liu F, Wu Y, Zhu Y, Jiang Y, Wu Q, et al. Inflammation in cancer: therapeutic opportunities from new insights. Mol Cancer. 2025;24(1):51. https:\/\/doi.org\/10.1186\/s12943-025-02243-8.","journal-title":"Mol Cancer"},{"issue":"9","key":"676_CR9","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/s41577-024-01026-4","volume":"24","author":"M De Martino","year":"2024","unstructured":"De Martino M, Rathmell JC, Galluzzi L, Vanpouille-Box C. Cancer cell metabolism and antitumour immunity. Nat Rev Immunol. 2024;24(9):654\u201369. https:\/\/doi.org\/10.1038\/s41577-024-01026-4.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"676_CR10","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12943-021-01428-1","volume":"20","author":"X Mao","year":"2021","unstructured":"Mao X, Xu J, Wang W, Liang C, Hua J, Liu J, et al. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives. Mol Cancer. 2021;20(1):131. https:\/\/doi.org\/10.1186\/s12943-021-01428-1.","journal-title":"Mol Cancer"},{"issue":"7","key":"676_CR11","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1002\/cac2.12579","volume":"44","author":"L Xiao","year":"2024","unstructured":"Xiao L, Zhang L, Guo C, Xin Q, Gu X, Jiang C, Wu J. Find Me and Eat Me signals: tools to drive phagocytic processes for modulating antitumor immunity. Cancer Commun (Lond). 2024;44(7):791\u2013832. https:\/\/doi.org\/10.1002\/cac2.12579.","journal-title":"Cancer Commun (Lond)"},{"issue":"1","key":"676_CR12","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s12943-024-02180-y","volume":"23","author":"X Zhou","year":"2024","unstructured":"Zhou X, Han J, Zuo A, Ba Y, Liu S, Xu H, et al. THBS2\u2009+\u2009cancer-associated fibroblasts promote EMT leading to oxaliplatin resistance via COL8A1-mediated PI3K\/AKT activation in colorectal cancer. Mol Cancer. 2024;23(1):282. https:\/\/doi.org\/10.1186\/s12943-024-02180-y.","journal-title":"Mol Cancer"},{"issue":"1","key":"676_CR13","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/s41467-022-28421-6","volume":"13","author":"Z Liu","year":"2022","unstructured":"Liu Z, Liu L, Weng S, Guo C, Dang Q, Xu H, et al. Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer. Nat Commun. 2022;13(1):816. https:\/\/doi.org\/10.1038\/s41467-022-28421-6.","journal-title":"Nat Commun"},{"issue":"8","key":"676_CR14","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1093\/nar\/gkv1507","volume":"44","author":"A Colaprico","year":"2016","unstructured":"Colaprico A, Silva TC, Olsen C, Garofano L, Cava C, Garolini D, et al. TCGAbiolinks: an R\/Bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res. 2016;44(8):e71. https:\/\/doi.org\/10.1093\/nar\/gkv1507.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"676_CR15","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","volume":"38","author":"MJ Goldman","year":"2020","unstructured":"Goldman MJ, Craft B, Hastie M, Repe\u010dka K, McDade F, Kamath A, et al. Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol. 2020;38(6):675\u20138. https:\/\/doi.org\/10.1038\/s41587-020-0546-8.","journal-title":"Nat Biotechnol"},{"key":"676_CR16","doi-asserted-by":"publisher","unstructured":"Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M et al. NCBI GEO: archive for functional genomics data sets\u2013update.Nucleic Acids Res.2013;41(Database issue):D991-D995. https:\/\/doi.org\/10.1093\/nar\/gks1193.","DOI":"10.1093\/nar\/gks1193"},{"issue":"14","key":"676_CR17","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1093\/bioinformatics\/btm254","volume":"23","author":"S Davis","year":"2007","unstructured":"Davis S, Meltzer PS. GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor. Bioinformatics. 2007;23(14):1846\u20137. https:\/\/doi.org\/10.1093\/bioinformatics\/btm254.","journal-title":"Bioinformatics"},{"issue":"5","key":"676_CR18","doi-asserted-by":"publisher","first-page":"e1001453","DOI":"10.1371\/journal.pmed.1001453","volume":"10","author":"L Marisa","year":"2013","unstructured":"Marisa L, de Reyni\u00e8s A, Duval A, Selves J, Gaub MP, Vescovo L, et al. Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value. PLoS Med. 2013;10(5):e1001453. https:\/\/doi.org\/10.1371\/journal.pmed.1001453.","journal-title":"PLoS Med"},{"key":"676_CR19","doi-asserted-by":"publisher","unstructured":"Stelzer G, Rosen N, Plaschkes I, Zimmerman S, Twik M, Fishilevich S, et al. The GeneCards Suite: From Gene Data Mining to Disease Genome Sequence Analyses. Curr Protoc Bioinformatics. 2016;54:1.30.1\u20131.30.33. https:\/\/doi.org\/10.1002\/cpbi.5.","DOI":"10.1002\/cpbi.5"},{"issue":"1","key":"676_CR20","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12943-021-01367-x","volume":"20","author":"M Herrera","year":"2021","unstructured":"Herrera M, Berral-Gonz\u00e1lez A, L\u00f3pez-Cade I, Galindo-Pumari\u00f1o C, Bueno-Fortes S, Mart\u00edn-Merino M, et al. Cancer-associated fibroblast-derived gene signatures determine prognosis in colon cancer patients. Mol Cancer. 2021;20(1):73. https:\/\/doi.org\/10.1186\/s12943-021-01367-x.","journal-title":"Mol Cancer"},{"key":"676_CR21","doi-asserted-by":"publisher","first-page":"978921","DOI":"10.3389\/fonc.2022.978921","volume":"12","author":"H Lu","year":"2022","unstructured":"Lu H, Zheng LY, Wu LY, Chen J, Xu N, Mi SC. The immune escape signature predicts the prognosis and immunotherapy sensitivity for pancreatic ductal adenocarcinoma. Front Oncol. 2022;12:978921. https:\/\/doi.org\/10.3389\/fonc.2022.978921.","journal-title":"Front Oncol"},{"issue":"7","key":"676_CR22","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47. https:\/\/doi.org\/10.1093\/nar\/gkv007.","journal-title":"Nucleic Acids Res"},{"key":"676_CR23","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/1471-2105-14-244","volume":"14","author":"H Zhang","year":"2013","unstructured":"Zhang H, Meltzer P, Davis S. RCircos: an R package for Circos 2D track plots. BMC Bioinformatics. 2013;14:244. https:\/\/doi.org\/10.1186\/1471-2105-14-244.","journal-title":"BMC Bioinformatics"},{"issue":"D1","key":"676_CR24","doi-asserted-by":"publisher","first-page":"D419","DOI":"10.1093\/nar\/gky1038","volume":"47","author":"H Mi","year":"2019","unstructured":"Mi H, Muruganujan A, Ebert D, Huang X, Thomas PD. PANTHER version 14: more genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools. Nucleic Acids Res. 2019;47(D1):D419\u201326. https:\/\/doi.org\/10.1093\/nar\/gky1038.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"676_CR25","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/nar\/28.1.27","volume":"27","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto SKEGG. Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 2000;27(1):29\u201334. https:\/\/doi.org\/10.1093\/nar\/28.1.27.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"676_CR26","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284\u20137. https:\/\/doi.org\/10.1089\/omi.2011.0118.","journal-title":"OMICS"},{"issue":"20","key":"676_CR27","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1093\/bioinformatics\/btt425","volume":"29","author":"EF Lock","year":"2013","unstructured":"Lock EF, Dunson DB. Bayesian consensus clustering. Bioinformatics. 2013;29(20):2610\u20136. https:\/\/doi.org\/10.1093\/bioinformatics\/btt425.","journal-title":"Bioinformatics"},{"issue":"12","key":"676_CR28","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","volume":"26","author":"MD Wilkerson","year":"2010","unstructured":"Wilkerson MD, Hayes DN. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics. 2010;26(12):1572\u20133. https:\/\/doi.org\/10.1093\/bioinformatics\/btq170.","journal-title":"Bioinformatics"},{"issue":"43","key":"676_CR29","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545\u201350. https:\/\/doi.org\/10.1073\/pnas.0506580102.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"676_CR30","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.otohns.2010.05.007","volume":"143","author":"JT Rich","year":"2010","unstructured":"Rich JT, Neely JG, Paniello RC, Voelker CC, Nussenbaum B, Wang EW. A practical guide to understanding Kaplan-Meier curves. Otolaryngol Head Neck Surg. 2010;143(3):331\u20136. https:\/\/doi.org\/10.1016\/j.otohns.2010.05.007.","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"7","key":"676_CR31","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/cac2.12067","volume":"40","author":"J Wu","year":"2020","unstructured":"Wu J, Zhang H, Li L, Hu M, Chen L, Xu B, et al. A nomogram for predicting overall survival in patients with low-grade endometrial stromal sarcoma: A population-based analysis. Cancer Commun (Lond). 2020;40(7):301\u201312. https:\/\/doi.org\/10.1002\/cac2.12067.","journal-title":"Cancer Commun (Lond)"},{"issue":"1","key":"676_CR32","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3348\/kjr.2004.5.1.11","volume":"5","author":"SH Park","year":"2004","unstructured":"Park SH, Goo JM, Jo CH. Receiver operating characteristic (ROC) curves: practical review for radiologists. Korean J Radiol. 2004;5(1):11\u20138. https:\/\/doi.org\/10.3348\/kjr.2004.5.1.11.","journal-title":"Korean J Radiol"},{"issue":"6","key":"676_CR33","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.eururo.2018.08.038","volume":"74","author":"B Van Calster","year":"2018","unstructured":"Van Calster B, Wynants L, Verbeek JFM, Verbakel JY, Christodoulou E, Vickers AJ, et al. Reporting and Interpreting Decision curves Analysis: A Guide for Investigators. Eur Urol. 2018;74(6):796\u2013804. https:\/\/doi.org\/10.1016\/j.eururo.2018.08.038.","journal-title":"Eur Urol"},{"issue":"D1","key":"676_CR34","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607\u201313. https:\/\/doi.org\/10.1093\/nar\/gky1131.","journal-title":"Nucleic Acids Res"},{"issue":"Suppl 4","key":"676_CR35","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1186\/1752-0509-8-S4-S11","volume":"8","author":"CH Chin","year":"2014","unstructured":"Chin CH, Chen SH, Wu HH, Ho CW, Ko MT, Lin CY. cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014;8(Suppl 4):S11. https:\/\/doi.org\/10.1186\/1752-0509-8-S4-S11.","journal-title":"BMC Syst Biol"},{"issue":"11","key":"676_CR36","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498\u2013504. https:\/\/doi.org\/10.1101\/gr.1239303.","journal-title":"Genome Res"},{"key":"676_CR37","doi-asserted-by":"publisher","first-page":"8957245","DOI":"10.1155\/2019\/8957245","volume":"2019","author":"X Yang","year":"2019","unstructured":"Yang X, Li Y, Lv R, Qian H, Chen X, Yang CF. Study on the Multitarget Mechanism and Key Active Ingredients of Herba Siegesbeckiae and Volatile Oil against Rheumatoid Arthritis Based on Network Pharmacology. Evid Based Complement Alternat Med. 2019;2019:8957245. https:\/\/doi.org\/10.1155\/2019\/8957245.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"5","key":"676_CR38","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453\u20137. https:\/\/doi.org\/10.1038\/nmeth.3337.","journal-title":"Nat Methods"},{"issue":"10","key":"676_CR39","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang P, Gu S, Pan D, Fu J, Sahu A, Hu X, et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med. 2018;24(10):1550\u20138. https:\/\/doi.org\/10.1038\/s41591-018-0136-1.","journal-title":"Nat Med"},{"issue":"1","key":"676_CR40","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13073-020-0721-z","volume":"12","author":"J Fu","year":"2020","unstructured":"Fu J, Li K, Zhang W, Wan C, Zhang J, Jiang P, et al. Large-scale public data reuse to model immunotherapy response and resistance. Genome Med. 2020;12(1):21. https:\/\/doi.org\/10.1186\/s13073-020-0721-z.","journal-title":"Genome Med"},{"issue":"269","key":"676_CR41","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6(269):pl1. https:\/\/doi.org\/10.1126\/scisignal.2004088.","journal-title":"Sci Signal"},{"issue":"1","key":"676_CR42","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","volume":"18","author":"P Charoentong","year":"2017","unstructured":"Charoentong P, Finotello F, Angelova M, Mayer C, Efremova M, Rieder D, et al. Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade. Cell Rep. 2017;18(1):248\u201362. https:\/\/doi.org\/10.1016\/j.celrep.2016.12.019.","journal-title":"Cell Rep"},{"issue":"7","key":"676_CR43","doi-asserted-by":"publisher","first-page":"BSR20201054","DOI":"10.1042\/BSR20201054","volume":"40","author":"J Fang","year":"2020","unstructured":"Fang J, Chen F, Liu D, Gu F, Chen Z, Wang Y. Prognostic value of immune checkpoint molecules in breast cancer. Biosci Rep. 2020;40(7):BSR20201054. https:\/\/doi.org\/10.1042\/BSR20201054.","journal-title":"Biosci Rep"},{"issue":"1","key":"676_CR44","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/s41392-025-02280-1","volume":"10","author":"M Tufail","year":"2025","unstructured":"Tufail M, Jiang CH, Li N. Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches. Signal Transduct Target Ther. 2025;10(1):227. https:\/\/doi.org\/10.1038\/s41392-025-02280-1.","journal-title":"Signal Transduct Target Ther"},{"issue":"11","key":"676_CR45","doi-asserted-by":"publisher","first-page":"102395","DOI":"10.1016\/j.xcrm.2025.102395","volume":"6","author":"V Boeker","year":"2025","unstructured":"Boeker V, Kalluri R. Insights into the relevance of targeting fibroblasts to control cancer. Cell Rep Med. 2025;6(11):102395. https:\/\/doi.org\/10.1016\/j.xcrm.2025.102395.","journal-title":"Cell Rep Med"},{"issue":"11","key":"676_CR46","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1016\/j.ccell.2022.09.015","volume":"40","author":"DS Foster","year":"2022","unstructured":"Foster DS, Januszyk M, Delitto D, Yost KE, Griffin M, Guo J, et al. Multiomic analysis reveals conservation of cancer-associated fibroblast phenotypes across species and tissue of origin. Cancer Cell. 2022;40(11):1392\u2013e14067. https:\/\/doi.org\/10.1016\/j.ccell.2022.09.015.","journal-title":"Cancer Cell"},{"issue":"5","key":"676_CR47","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s00418-014-1293-z","volume":"143","author":"B Dvo\u0159\u00e1nkov\u00e1","year":"2015","unstructured":"Dvo\u0159\u00e1nkov\u00e1 B, Smetana K Jr, \u0158\u00edhov\u00e1 B, Ku\u010dera J, Mateu R, Szabo P. Cancer-associated fibroblasts are not formed from cancer cells by epithelial-to-mesenchymal transition in nu\/nu mice. Histochem Cell Biol. 2015;143(5):463\u20139. https:\/\/doi.org\/10.1007\/s00418-014-1293-z.","journal-title":"Histochem Cell Biol"},{"key":"676_CR48","doi-asserted-by":"publisher","unstructured":"Qi J, Sun H, Zhang Y, Wang Z, Xun Z, Li Z et al. Single-cell and spatial analysis reveal interaction of FAP+ fibroblasts and SPP1+ macrophages in colorectal cancer. Nat Commun. 2022;13(1):1742. Published 2022 Apr 1. https:\/\/doi.org\/10.1038\/s41467-022-29366-6.","DOI":"10.1038\/s41467-022-29366-6"},{"issue":"3","key":"676_CR49","doi-asserted-by":"publisher","first-page":"449","DOI":"10.3350\/cmh.2024.0047","volume":"30","author":"Y Zheng","year":"2024","unstructured":"Zheng Y, Zhao L, Xiong Z, Huang C, Yong Q, Fang D, et al. Ursolic acid targets secreted phosphoprotein 1 to regulate Th17 cells against metabolic dysfunction-associated steatotic liver disease. Clin Mol Hepatol. 2024;30(3):449\u201367. https:\/\/doi.org\/10.3350\/cmh.2024.0047.","journal-title":"Clin Mol Hepatol"},{"key":"676_CR50","doi-asserted-by":"publisher","unstructured":"Liu S, Zhang Z, Wang Z, Liu C, Liang G, Xu T, et al. SPP1 Drives Colorectal Cancer Liver Metastasis and Immunotherapy Resistance by Stimulating CXCL12 Production in Cancer-Associated Fibroblasts. Cancer Res Published online Oct. 2025;6. https:\/\/doi.org\/10.1158\/0008-5472.CAN-24-4916.","DOI":"10.1158\/0008-5472.CAN-24-4916"},{"issue":"21","key":"676_CR51","doi-asserted-by":"publisher","first-page":"4049","DOI":"10.1158\/0008-5472.CAN-25-1486","volume":"85","author":"Y Gu","year":"2025","unstructured":"Gu Y, Muller WJ. The Multifaceted Role of Osteopontin in Modulating the Tumor Microenvironment. Cancer Res. 2025;85(21):4049\u201361. https:\/\/doi.org\/10.1158\/0008-5472.CAN-25-1486.","journal-title":"Cancer Res"},{"issue":"3","key":"676_CR52","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.ccell.2023.02.004","volume":"41","author":"N Bancaro","year":"2023","unstructured":"Bancaro N, Cal\u00ec B, Troiani M, et al. Apolipoprotein E induces pathogenic senescent-like myeloid cells in prostate cancer. Cancer Cell. 2023;41(3):602\u2013e61911. https:\/\/doi.org\/10.1016\/j.ccell.2023.02.004.","journal-title":"Cancer Cell"},{"issue":"15","key":"676_CR53","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1158\/0008-5472.CAN-24-2528","volume":"85","author":"X Lou","year":"2025","unstructured":"Lou X, Shi Y, Zhao F, Xu X, Wang Y, Qin Y, et al. Pancreatic Neuroendocrine Tumors Secrete Apolipoprotein E to Induce Tip Endothelial Cells That Remodel the Tumor-Stroma Ratio and Promote Cancer Progression. Cancer Res. 2025;85(15):2805\u201319. https:\/\/doi.org\/10.1158\/0008-5472.CAN-24-2528.","journal-title":"Cancer Res"},{"key":"676_CR54","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ctrv.2017.11.007","volume":"63","author":"R Tokunaga","year":"2018","unstructured":"Tokunaga R, Zhang W, Naseem M, Puccini A, Berger MD, Soni S, et al. CXCL9, CXCL10, CXCL11\/CXCR3 axis for immune activation - A target for novel cancer therapy. Cancer Treat Rev. 2018;63:40\u20137. https:\/\/doi.org\/10.1016\/j.ctrv.2017.11.007.","journal-title":"Cancer Treat Rev"},{"issue":"3","key":"676_CR55","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/s41419-021-03545-7","volume":"12","author":"G Liu","year":"2021","unstructured":"Liu G, Sun J, Yang ZF, Zhou C, Zhou PY, Guan RY, et al. Cancer-associated fibroblast-derived CXCL11 modulates hepatocellular carcinoma cell migration and tumor metastasis through the circUBAP2\/miR-4756\/IFIT1\/3 axis. Cell Death Dis. 2021;12(3):260. https:\/\/doi.org\/10.1038\/s41419-021-03545-7.","journal-title":"Cell Death Dis"},{"issue":"1","key":"676_CR56","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s13578-024-01308-3","volume":"14","author":"SH Hwang","year":"2024","unstructured":"Hwang SH, Yang Y, Jung JH, Kim JW, Kim Y. Stearoyl-CoA desaturase in CD4+ T cells suppresses tumor growth through activation of the CXCR3\/CXCL11 axis in CD8+ T cells. Cell Biosci. 2024;14(1):137. https:\/\/doi.org\/10.1186\/s13578-024-01308-3.","journal-title":"Cell Biosci"},{"issue":"1","key":"676_CR57","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s40425-019-0706-x","volume":"7","author":"M Bilusic","year":"2019","unstructured":"Bilusic M, Heery CR, Collins JM, Donahue RN, Palena C, Madan RA, et al. Phase I trial of HuMax-IL8 (BMS-986253), an anti-IL-8 monoclonal antibody, in patients with metastatic or unresectable solid tumors. J Immunother Cancer. 2019;7(1):240. https:\/\/doi.org\/10.1186\/s40425-019-0706-x.","journal-title":"J Immunother Cancer"},{"issue":"1","key":"676_CR58","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12967-025-07557-1","volume":"24","author":"B Li","year":"2026","unstructured":"Li B, Lau LY, Chen Y. Linking FAM111B to metabolic-immune remodeling in breast ductal carcinoma. J Transl Med. 2026;24(1):177. https:\/\/doi.org\/10.1186\/s12967-025-07557-1.","journal-title":"J Transl Med"},{"issue":"21","key":"676_CR59","doi-asserted-by":"publisher","first-page":"e71317","DOI":"10.1002\/cam4.71317","volume":"14","author":"Y Chen","year":"2025","unstructured":"Chen Y, Bai M, Liu M, Zhang Z, Jiang C, Li K, et al. Metabolic Reprogramming in Lung Cancer: Hallmarks, Mechanisms, and Targeted Strategies to Overcome Immune Resistance. Cancer Med. 2025;14(21):e71317. https:\/\/doi.org\/10.1002\/cam4.71317.","journal-title":"Cancer Med"},{"key":"676_CR60","doi-asserted-by":"publisher","first-page":"1694587","DOI":"10.3389\/fonc.2025.1694587","volume":"15","author":"K Wang","year":"2025","unstructured":"Wang K, Zhang B, Li K, Zhang Z, Zeng X, Guan JM, et al. Novel immune-nutritional prognostic ratio predicts long-term survival in stage I-III colorectal cancer. Front Oncol. 2025;15:1694587. https:\/\/doi.org\/10.3389\/fonc.2025.1694587.","journal-title":"Front Oncol"},{"issue":"1","key":"676_CR61","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1186\/s12885-025-15165-x","volume":"25","author":"K Li","year":"2025","unstructured":"Li K, Zhang R, Zhang J, Zhang Z, Wang K, Lu Y, et al. The prognostic role of inflammation-based hematologic markers in stage I-III colorectal cancer: a retrospective analysis. BMC Cancer. 2025;25(1):1822. https:\/\/doi.org\/10.1186\/s12885-025-15165-x.","journal-title":"BMC Cancer"}],"container-title":["Hereditas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41065-026-00676-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-026-00676-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-026-00676-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:34:08Z","timestamp":1781645648000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41065-026-00676-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,7]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["676"],"URL":"https:\/\/doi.org\/10.1186\/s41065-026-00676-9","relation":{},"ISSN":["1601-5223"],"issn-type":[{"value":"1601-5223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,7]]},"assertion":[{"value":"4 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Inner Mongolia Medical University (7\/2024\/YKD202403015).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"60"}}